-
公开(公告)号:US5912009A
公开(公告)日:1999-06-15
申请号:US959944
申请日:1997-10-29
IPC分类号: A61F13/02 , A61K9/00 , A61K9/70 , A61K31/196 , A61K31/506 , A61K31/522 , A61K31/565 , A61K31/568 , A61K47/14
CPC分类号: A61K9/7061 , A61K47/14 , A61K9/0014 , Y10S514/946 , Y10S514/947
摘要: A transdermal drug delivery system which enhances the delivery of the drug comprises a composition containing, as an enhancer, one or more C.sub.6 to C.sub.22 fatty acid esters of glycolic acid and its salts. These compositions are made up of a safe and effective amount of an active pharmaceutical permeant contained in a penetration-enhancing vehicle comprising, 0.25 to 50% w. of the fatty acid glycolic acid ester enhancer in a suitable carrier vehicle. These fatty acid glycolic acid ester enhancers may be used in various carrier vehicles to enhance the transdermal delivery of active permeants in either free form or used in an occlusive device, particularly in a transdermal patch in matrix or reservoir form. When used in matrix patch form, the fatty acid glycolic acid ester enhancers and permeants are incorporated into a biocompatible adhesive. When used in a reservoir type patch, the permeant and fatty acid glycolic acid ester enhancers are incorporated into a carrier fluid of controlled viscosity such as a gel or ointment preferably containing a lower alkanol and water. In free form, the enhancer and permeant may be incorporated into an ointment, lotion, cream, or similar formulation.
摘要翻译: 增强药物递送的透皮药物递送系统包含含有一种或多种乙醇酸及其盐的一种或多种C 6至C 22脂肪酸酯作为增强剂的组合物。 这些组合物由安全有效量的包含在穿透增强载体中的活性药物渗透剂组成,其包含0.25至50重量%的w。 的脂肪酸乙醇酸酯增强剂在合适的载体载体中。 这些脂肪酸乙醇酸酯增强剂可用于各种载体载体中,以增强游离形式的活性渗透物的透皮递送或用于闭塞装置,特别是基质或储液器形式的透皮贴剂。 当以基质斑块形式使用时,将脂肪酸乙醇酸酯增强剂和渗透剂掺入生物相容性粘合剂中。 当用于储层型贴片时,将渗透剂和脂肪酸乙醇酸酯增强剂掺入到受控粘度的载体流体中,例如优选含有低级链烷醇和水的凝胶或软膏剂。 以游离形式,增强剂和渗透剂可以掺入软膏,洗剂,霜剂或类似制剂中。
-
公开(公告)号:US5952000A
公开(公告)日:1999-09-14
申请号:US959946
申请日:1997-10-29
IPC分类号: A61F13/02 , A61K9/00 , A61K9/70 , A61K31/196 , A61K31/506 , A61K31/522 , A61K31/565 , A61K31/568 , A61K47/14
CPC分类号: A61K9/7061 , A61K47/14 , A61K9/0014 , Y10S514/946 , Y10S514/947
摘要: A transdermal drug delivery system which enhances the delivery of the drug comprises a composition containing, as an enhancer, one or more C.sub.6 to C.sub.22 fatty acid esters of a lactic acid salt. These compositions are made up of a safe and effective amount of an active pharmaceutical permeant contained in a penetration-enhancing vehicle comprising, 0.25 to 50% w. of the fatty acid ester of a lactic acid salt enhancer in a suitable pressure sensitive adhesive carrier vehicle formed from and aqueous emulsion based pressure sensitive adhesive.
摘要翻译: 增强药物递送的透皮药物递送系统包括含有乳酸盐的一种或多种C 6至C 22脂肪酸酯作为增强剂的组合物。 这些组合物由安全有效量的包含在穿透增强载体中的活性药物渗透剂组成,其包含0.25至50重量%的w。 的乳酸盐增强剂的脂肪酸酯在由基于乳液的压敏粘合剂形成的合适的压敏粘合剂载体载体中。
-